We propose to investigate 4 important questions in the areas of marrow transplantation and total body irradiation (TB1). Answers to these questions have relevance to human marrow transplantation for the treatment of patients with malignant and nonmalignant hematological diseases. We plan to carry out the studies in a well established preclinical model using random bred dogs. The first 3 questions relate to host versus graft reactions and the design of conditioning programs, and the fourth addresses a complication commonly seen after successful engraftment, graft versus host disease (GVHD). With regard to host versus graft """"""""resistance"""""""", we plan to extend our previous studies on the graft enhancing ability of a monoclonal antibody (MAb) directed against CD44. This will include investigations of other anti-CD44 MAbs which, in part, have better cross-reactivity with human cells. We are cloning the gene coding for canine CD44; once sequencing of the cDNA is completed we will attempt to generate products from sub full length clones. These products could be used to determine which of the reactive epitopes is important in resistance to marrow grafts. Other MAbs directed against the leukocyte adhesion family of antigens may be investigated. Restriction fragment length polymorphism analyses of DLA class I and II antigens enable us to ask questions about the role of these antigens in graft resistance in unrelated marrow grafts MAbs to canine natural killer (NK) antigens will become available and will permit us to investigate the role of NK cells in engraftment or resistance. Certain new immunosuppressive agents will be evaluated for their ability to overcome resistance. Results of these studies are important for extending marrow transplantation to include more HLA-nonidentical and unrelated transplant recipients. We plan to explore novel conditioning regiments using MAbs coupled to short lived radioactive isotopes which deposit their energy within a narrow radius. By targeting the radiation with the help of a MAb we hope to avoid the toxicity generally seen with high-dose TBI programs. Also, the more intensive conditioning achieved with this approach is likely to set the stage for more successful application of T-cell depleted marrow grafts. Also we plan to develop improved TBI regimens. We will compare the toxicity and immunosuppressive properties of fractionated and single-dose TBI delivered at high dose rates. These studies have obvious implications for the design of clinical conditioning programs. Finally, we propose to investigate new immunosuppressive agents for prevention and treatment of acute GVHD in dogs. Promising new approaches may then be explored clinically, initially in the setting of steroid- resistant acute GVHD.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA031787-13
Application #
3169898
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1981-05-01
Project End
1996-02-28
Budget Start
1993-03-01
Budget End
1994-02-28
Support Year
13
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
Wagner, J L; Burnett, R C; Storb, R (1999) Organization of the canine major histocompatibility complex: current perspectives. J Hered 90:35-8
Yamaguchi, M; McSweeney, P A; Kimball, L et al. (1999) Recognition of major histocompatibility complex class II antigens by two anti-HLA-DR monoclonal antibodies on canine marrow cells correlates with effects on in vitro and in vivo hematopoiesis. Transplantation 68:1161-71
Huss, R; Theis, S; Deeg, H J (1999) CDK-inhibitor independent cell cycle progression in an experimental haematopoietic stem cell leukaemia despite unaltered Rb-phosphorylation. Br J Cancer 81:808-13
Graumann, M B; DeRose, S A; Ostrander, E A et al. (1998) Polymorphism analysis of four canine MHC class I genes. Tissue Antigens 51:374-81
Storb, R; Raff, R; Deeg, H J et al. (1998) Dose rate-dependent sparing of the gastrointestinal tract by fractionated total body irradiation in dogs given marrow autografts. Int J Radiat Oncol Biol Phys 40:961-6
Sandmaier, B M; Storb, R; Bennett, K L et al. (1998) Epitope specificity of CD44 for monoclonal antibody-dependent facilitation of marrow engraftment in a canine model. Blood 91:3494-502
Yu, C; Seidel, K; Nash, R A et al. (1998) Synergism between mycophenolate mofetil and cyclosporine in preventing graft-versus-host disease among lethally irradiated dogs given DLA-nonidentical unrelated marrow grafts. Blood 91:2581-7
Krizanac-Bengez, L; Moore, P F; Barsoukov, A et al. (1998) The expression and differentiation pattern of cell antigens and adhesion molecules on the nonadherent cell population in canine long-term marrow culture: a biphasic development of myeloid and lymphoid cells. Tissue Antigens 51:141-55
Burnett, R C; DeRose, S A; Wagner, J L et al. (1997) Molecular analysis of six dog leukocyte antigen class I sequences including three complete genes, two truncated genes and one full-length processed gene. Tissue Antigens 49:484-95
Huss, R; Myerson, D H; Deeg, H J (1997) Haematopoietic progenitor cells transfected with a differentiation antigen show cellular transformation and tumour growth in mice. Int J Exp Pathol 78:177-85

Showing the most recent 10 out of 165 publications